Granite Creek Capital Partners today announced the promotion of Jordan Liss to Principal.
Jordan joined Granite Creek in 2018 and has been a key contributor to the firm’s growth and success. Jordan continues to make his mark on Granite Creek through his efforts in identifying, evaluating, and executing investments as well as fundraising, business development, and portfolio management. He currently serves on the board of Granite Creek Portfolio companies Veterinary Pharmaceutical Solutions, CP Direct, and Salem One.
One of Jordan’s many achievements at the firm includes his integral role in the sale of Morrow Sodali, the leading global shareholder engagement and governance advisory firm. Most recently, Jordan has led successful investments in two stand-alone companies in the printing and packaging industries, CP Direct and Salem One.
“Jordan has been a tremendous team member,” said Brian Boorstein, Co-Founder and Partner at Granite Creek. “His strategic insight, leadership, technical abilities, and passion have led to significant accomplishments for the firm and its subsequent portfolio companies.”
This promotion is a direct reflection of Jordan’s meaningful and impactful contributions to the firm. Jordan consistently performs at the highest level, and we are excited to see what’s to come in his expanded leadership role.”Mark Radzik, Co-Founder and Managing Partner at Granite Creek
Jordan joined Granite Creek as an Associate in 2018. Prior to Granite Creek, he was an Analyst at Livingstone Partners, where he primarily worked on middle-market sell-side transactions. He holds a B.B.A. from the University of Michigan’s Ross School of Business, where he graduated with honors. Jordan is a Hodgkin Lymphoma survivor and is actively involved in philanthropic organizations through Northwestern Memorial Hospital.